Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-017831
Filing Date
2025-07-03
Accepted
2025-07-03 16:45:31
Documents
1
Period of Report
2025-07-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4942
  Complete submission text file 0001641172-25-017831.txt   6339
Mailing Address 2570 W. EL CAMINO REAL, STE. 320, MOUNTAIN VIEW CA 94040
Business Address 2570 W. EL CAMINO REAL, STE. 320, MOUNTAIN VIEW CA 94040 408-800-2649
RenovoRx, Inc. (Issuer) CIK: 0001574094 (see all company filings)

EIN.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3124 BROTHER BLVD SUITE 104 BARTLETT TN 38133
Business Address
Gentry Leesa (Reporting) CIK: 0002013097 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40738 | Film No.: 251106104